Search Page

1

Cite

Share

Carotid body: a metabolic sensor implicated in insulin resistance.

Conde SV, Sacramento JF, Guarino MP. Conde SV, et al. Among authors: sacramento jf. Physiol Genomics. 2018 Mar 1;50(3):208-214. doi: 10.1152/physiolgenomics.00121.2017. Epub 2018 Jan 26. Physiol Genomics. 2018. PMID: 29373079 Review.

Cite

Share

2

Cite

Share

Immunity and the carotid body: implications for metabolic diseases.

Conde SV, Sacramento JF, Martins FO. Conde SV, et al. Among authors: sacramento jf. Bioelectron Med. 2020 Dec 23;6(1):24. doi: 10.1186/s42234-020-00061-5. Bioelectron Med. 2020. PMID: 33353562 Free PMC article. Review.

Cite

Share

3

Cite

Share

Purines and Carotid Body: New Roles in Pathological Conditions.

Conde SV, Monteiro EC, Sacramento JF. Conde SV, et al. Among authors: sacramento jf. Front Pharmacol. 2017 Dec 12;8:913. doi: 10.3389/fphar.2017.00913. eCollection 2017. Front Pharmacol. 2017. PMID: 29311923 Free PMC article. Review.

Cite

Share

4

Cite

Share

Insulin resistance: a new consequence of altered carotid body chemoreflex?

Conde SV, Ribeiro MJ, Melo BF, Guarino MP, Sacramento JF. Conde SV, et al. Among authors: sacramento jf. J Physiol. 2017 Jan 1;595(1):31-41. doi: 10.1113/JP271684. Epub 2016 Jun 27. J Physiol. 2017. PMID: 27027507 Free PMC article. Review.

Cite

Share

5

Cite

Share

Carotid body chemosensitivity: early biomarker of dysmetabolism in humans.

Cunha-Guimaraes JP, Guarino MP, Timóteo AT, Caires I, Sacramento JF, Ribeiro MJ, Selas M, Santiago JCP, Mota-Carmo M, Conde SV. Cunha-Guimaraes JP, et al. Among authors: sacramento jf. Eur J Endocrinol. 2020 Jun;182(6):549-557. doi: 10.1530/EJE-19-0976. Eur J Endocrinol. 2020. PMID: 32213652

Cite

Share

6

Cite

Share

Chronic Intermittent Hypoxia Induces Early-Stage Metabolic Dysfunction Independently of Adipose Tissue Deregulation.

Martins FO, Sacramento JF, Olea E, Melo BF, Prieto-Lloret J, Obeso A, Rocher A, Matafome P, Monteiro EC, Conde SV. Martins FO, et al. Among authors: sacramento jf. Antioxidants (Basel). 2021 Jul 30;10(8):1233. doi: 10.3390/antiox10081233. Antioxidants (Basel). 2021. PMID: 34439481 Free PMC article.

Cite

Share

7

Cite

Share

Carotid body, insulin, and metabolic diseases: unraveling the links.

Conde SV, Sacramento JF, Guarino MP, Gonzalez C, Obeso A, Diogo LN, Monteiro EC, Ribeiro MJ. Conde SV, et al. Among authors: sacramento jf. Front Physiol. 2014 Oct 29;5:418. doi: 10.3389/fphys.2014.00418. eCollection 2014. Front Physiol. 2014. PMID: 25400585 Free PMC article. Review.

Cite

Share

8

Cite

Share

Exploring the Mediators that Promote Carotid Body Dysfunction in Type 2 Diabetes and Obesity Related Syndromes.

Sacramento JF, Andrzejewski K, Melo BF, Ribeiro MJ, Obeso A, Conde SV. Sacramento JF, et al. Int J Mol Sci. 2020 Aug 3;21(15):5545. doi: 10.3390/ijms21155545. Int J Mol Sci. 2020. PMID: 32756352 Free PMC article. Review.

Cite

Share

9

Cite

Share

Type 2 diabetes progression differently affects endothelial function and vascular contractility in the aorta and the pulmonary artery.

Melo BF, Prieto-Lloret J, Cabral MD, Martins FO, Martins IB, Sacramento JF, Ruivo P, Carvalho T, Conde SV. Melo BF, et al. Among authors: sacramento jf. Sci Rep. 2021 Mar 15;11(1):6052. doi: 10.1038/s41598-021-85606-7. Sci Rep. 2021. PMID: 33723367 Free PMC article.

Cite

Share

10

Cite

Share

Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes.

Tavares G, Marques D, Barra C, Rosendo-Silva D, Costa A, Rodrigues T, Gasparini P, Melo BF, Sacramento JF, Seiça R, Conde SV, Matafome P. Tavares G, et al. Among authors: sacramento jf. Mol Metab. 2021 Sep;51:101241. doi: 10.1016/j.molmet.2021.101241. Epub 2021 Apr 29. Mol Metab. 2021. PMID: 33933677 Free PMC article.

Cite

Share